RICE HALL JAMES & ASSOCIATES, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,608,991
+37.7%
157,426
-1.0%
0.23%
+53.7%
Q2 2023$2,621,234
-4.5%
158,959
+3.4%
0.15%
-4.5%
Q1 2023$2,743,542
-38.5%
153,786
+0.4%
0.16%
-39.1%
Q4 2022$4,461,242
+6.9%
153,202
-10.1%
0.26%
+5.8%
Q3 2022$4,174,000
+532.4%
170,357
+7.1%
0.24%
+656.2%
Q2 2022$660,000
-58.0%
159,000
+16.5%
0.03%
-49.2%
Q1 2022$1,573,000
+23.6%
136,521
+7.0%
0.06%
+40.0%
Q4 2021$1,273,000
-34.9%
127,546
-14.8%
0.04%
-37.5%
Q3 2021$1,955,000
-30.6%
149,720
+4.0%
0.07%
-28.0%
Q2 2021$2,819,000
+106.2%
143,994
+124.1%
0.10%
+122.2%
Q1 2021$1,367,000
-5.7%
64,261
+31.9%
0.04%
-11.8%
Q4 2020$1,449,000
+22.5%
48,723
-10.7%
0.05%
+6.2%
Q3 2020$1,183,000
+42.5%
54,591
+46.7%
0.05%
+33.3%
Q2 2020$830,000
-11.9%
37,210
-39.9%
0.04%
-32.1%
Q1 2020$942,000
-33.0%
61,914
+1.0%
0.05%
+10.4%
Q4 2019$1,407,000
+0.6%
61,295
-5.4%
0.05%
-4.0%
Q3 2019$1,399,000
+0.6%
64,804
+2.5%
0.05%
+8.7%
Q2 2019$1,391,000
+118.7%
63,217
+172.5%
0.05%
+130.0%
Q1 2019$636,00023,2020.02%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders